HBR REALTY (HBRE3) Main Indicators
Basic Data - HBRE3
| Company | HBR REALTY |
| Corporate Name | HBR REALTY EMPREENDIMENTOS IMOBILIARIOS S/A |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Deter patrimônio constituído por bens imóveis e direitos a eles relativos; administrar bens imóveis próprios e de terceiros; e participar. como sócia ou acionista. em outras sociedades. |
| Share | HBRE3 |
| Quote Date | 04/01/2025 |
| Share Type | ON |
| Last Closing | R$ 3.42 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 451.61 thousand |
| Last Statement | DFP - 12/31/2024 |
| Sector | Financeiro |
| Subsector | Exploração de Imóveis |
| Segment | Exploração de Imóveis |
| Participation Indexes | IGC, IGNM, ITAG |
| Updated 04/02/2025 | |
Relative Prices - HBRE3
| Price/Earnings | 7.41 |
| Price/SBV | 0.17 |
| Price/Net Sales | 2.17 |
| Price/CFO | -3.36 |
| Price/FCF | -2.49 |
| Price/Total Assets | 0.07 |
| Price/EBIT | 1.25 |
| Price/Working Capital | 1.88 |
| Price/NCAV | -0.12 |
| EV/EBIT | 6.57 |
| EV/EBITDA | 6.47 |
| EV/Net Sales | 11.36 |
| EV/CFO | -17.62 |
| EV/FCF | -13.08 |
| EV/Total Assets | 0.36 |
| Company Market Cap | R$ 352.91 M |
| Enterprise Value | R$ 1.85 B |
| Current Financial Statement Date | 12/31/2024 |
| Current Share Price | R$ 3.42 |
| Share Price Date | 04/01/2025 |
| Dividend Yield | 0.00% |
| Updated 04/02/2025 | |
Income Statement - HBRE3
| Net Revenue | R$ 162.98 M |
| Gross Result | R$ 129.98 M |
| EBIT | R$ 281.93 M |
| Depreciation and Amortization | - R$ 4.54 M |
| EBITDA | R$ 286.47 M |
| Net Profit | R$ 47.65 M |
| Net Profit/Share | R$ 0.46 |
| Updated 03/11/2025 | |
| Net Revenue | R$ 43.98 M |
| Gross Result | R$ 34.48 M |
| EBIT | R$ 226.18 M |
| Depreciation and Amortization | - R$ 1.18 M |
| EBITDA | R$ 227.36 M |
| Net Profit | R$ 100.37 M |
| Profit/Share | R$ 0.97 |
| Updated 03/11/2025 | |
Price and Volume Behavior - HBRE3
| Lowest Price 52 weeks | R$ 2.61 |
| Highest Price 52 weeks | R$ 6.16 |
| Variation 2025 | 9.97% |
| Variation 1 year | -44.03% |
| Variation 2 years(total) | -11.63% |
| Variation 2 years(yearly) | -5.98% |
| Variation 3 years(total) | -50.22% |
| Variation 3 years(yearly) | -20.73% |
| Variation 4 years(total) | -79.27% |
| Variation 4 years(yearly) | -32.51% |
| Variation 5 years(total) | - |
| Variation 5 years(yearly) | - |
| Average Daily Volume (3 months) | R$ 1.05 M |
| Updated 04/02/2025 | |
Returns and Margins - HBRE3
| Return on Initial Tangible Capital | 4.17% |
| Return on Initial Invested Capital | 5.73% |
| Pre-Tax Return on Initial Tangible Capital | 6.32% |
| Pre-Tax Return on Initial Invested Capital | 8.68% |
| Return on Initial Shareholder´s Equity | 2.35% |
| Return on Initial Asset | 1.02% |
| Gross Margin | 79.75% |
| Net Margin | 29.23% |
| EBIT Margin | 172.98% |
| EBITDA Margin | 175.77% |
| Initial Asset Turnover | 0.03 |
| Financial Leverage | 2.46 |
| Liabilities/Net Worth | 1.46 |
| Net Debt/EBITDA | 5.23 |
| Updated 03/11/2025 | |
Balance Sheet - HBRE3
| Cash and Cash Equivalents | R$ 27.24 M |
| Total Assets | R$ 5.09 B |
| Short-Term Debt | R$ 143.54 M |
| Long-Term Debt | R$ 1.38 B |
| Gross Debt | R$ 1.53 B |
| Net Debt | R$ 1.50 B |
| Shareholder´s Equity | R$ 2.07 B |
| Share Book Value | R$ 20.05 |
| Common Shares | 103,188,981 |
| Preferred Shares | 0 |
| Total | 103,188,981 |
| Common Shares in Treasury | 287,649 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 287,649 |
| Common Shares (Except Treasury) | 102,901,332 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 102,901,332 |
| Updated 03/11/2025 | |
Cash Flow - HBRE3
| Operating Cash Flow | - R$ 105.13 M |
| Cash Flow from Investments | - R$ 106.44 M |
| Financing Cash Flow | R$ 217.93 M |
| Increase (Reduction) in Cash and Equivalents | R$ 6.36 M |
| Updated 03/11/2025 | |
| Operating Cash Flow | R$ 20.00 M |
| Cash Flow from Investments | - R$ 57.33 M |
| Financing Cash Flow | R$ 40.34 M |
| Increase (Reduction) in Cash and Equivalents | R$ 3.01 M |
| Updated 03/11/2025 | |
Experimental - HBRE3
| CAPEX 3 months | - R$ 3.80 M |
| Free Cash Flow 3 months | R$ 16.20 M |
| CAPEX 12 months | - R$ 36.50 M |
| Free Cash Flow 12 months | - R$ 141.62 M |
| Updated 03/11/2025 | |